The role of complement in the clinical course of hepatocellular carcinoma

The role of complement in the clinical course of hepatocellular carcinoma

Abstract Background The complement system, an innate immune system, may either play an antitumor role, or promote tumorigenesis and cancer progression in different kinds of cancer. The function of complement in hepatocellular carcinoma (HCC) is unclear. Methods The gene expressions of the complement...

Full description

Bibliographic Details
Main Authors:	Xinye Qian, Zhoujing Yang, Lu Gao, Yipiao Liu, Jun Yan
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Series:	Immunity, Inflammation and Disease
Subjects:	complement hepatocellular carcinoma immune infiltration Kaplan–Meier plotter prognosis
Online Access:	https://doi.org/10.1002/iid3.569

Similar Items

Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in Hepatocellular Carcinoma
by: Zhou A, et al.
Published: (2020-10-01)

Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
by: Huang Y, et al.
Published: (2019-02-01)

Prognostic values of S100 family members in ovarian cancer patients
by: Yang Bai, et al.
Published: (2018-12-01)

Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma
by: Huang Run, et al.
Published: (2022-08-01)

Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system
by: Ni F, et al.
Published: (2019-09-01)

Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC
by: Weiyang Lou, et al.
Published: (2019-01-01)

Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer
by: Wang JY, et al.
Published: (2018-06-01)

Clinical data analysis of CDKs expression and prognosis in breast cancer
by: X.-J. Bao, et al.
Published: (2023-01-01)

Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
by: Qiong Luo, et al.
Published: (2020-11-01)

An evaluation on diagnosis and management patterns of patients with oral squamous cell carcinoma referred to the Cancer Institute of Tehran Medical University during 2010-2021
by: Ata Garajei, et al.
Published: (2023-04-01)

A Comparison between Kaplan-Meier and Weighted Kaplan-Meier Methods of Five-Year Survival Estimation of Patients with Gastric Cancer
by: Ali Zare, et al.
Published: (2014-10-01)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
by: Shanshan Liu, et al.
Published: (2021-09-01)

Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma
by: Ju-Yan Zheng, et al.
Published: (2022-07-01)

The Prognosis Of Peroxiredoxin Family In Breast Cancer
by: Wang G, et al.
Published: (2019-11-01)

OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts
by: Jiaxing Lin, et al.
Published: (2021-11-01)

Evaluation of the Role of Neck Dissection in Patients with Verrucous Squamous Cell Carcinoma of the Oral Cavity: A Cohort Study
by: ANOOP Attakki, et al.
Published: (2023-12-01)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
by: Shuqiao Zhang, et al.
Published: (2022-01-01)

ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis
by: Xuan Wang, et al.
Published: (2023-07-01)

PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
by: Wen-Feng Liu, et al.
Published: (2022-11-01)

ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
by: Lin T, et al.
Published: (2021-10-01)

A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma
by: Yuyao Li, et al.
Published: (2022-10-01)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
by: Tianhao Cong, et al.
Published: (2022-10-01)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
by: Danjun Song, et al.
Published: (2020-07-01)

An update on the role of complement in hepatocellular carcinoma
by: Zhijie Xiao, et al.
Published: (2022-10-01)

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
by: Hongjun Yu, et al.
Published: (2022-06-01)

Is There a Two-Way Risk between Decreased Testosterone Levels and the Progression and Prognosis of Chronic Kidney Disease? A Cohort Study Based on the National Health and Nutrition Examination Survey Database
by: Jiashan Pan, et al.
Published: (2024-04-01)

A nomogram for predicting prognosis of patients with cervical cerclage
by: Jiaqi Xu, et al.
Published: (2023-11-01)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
by: Jin Hu, et al.
Published: (2021-05-01)

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma
by: Chenxi Pan, et al.
Published: (2022-05-01)

NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma
by: Rongqiang Liu, et al.
Published: (2021-12-01)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
by: Qinglin Ding, et al.
Published: (2022-10-01)

Kaplan-Meier Survival Analysis: Practical Insights for Clinicians
by: António Pedro Gomes, et al.
Published: (2024-04-01)

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
by: Kunfu Dai, et al.
Published: (2022-05-01)

Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation
by: Renguo Guan, et al.
Published: (2022-07-01)

Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma
by: Zhongqiang Qin, et al.
Published: (2024-01-01)

PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
by: Wenzhi Jin, et al.
Published: (2024-03-01)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
by: Jianhui Li, et al.
Published: (2022-01-01)

CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2022-09-01)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
by: Xiangqian Gu, et al.
Published: (2022-10-01)

RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
by: Haiyuan Li, et al.
Published: (2023-01-01)